These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29279995)

  • 1. Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.
    Naoi M; Maruyama W; Shamoto-Nagai M
    J Neural Transm (Vienna); 2018 Nov; 125(11):1635-1650. PubMed ID: 29279995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.
    Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2013 Mar; 120(3):435-44. PubMed ID: 22968599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
    Naoi M; Riederer P; Maruyama W
    J Neural Transm (Vienna); 2016 Feb; 123(2):91-106. PubMed ID: 25604428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase.
    Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2012 Apr; 119(4):405-14. PubMed ID: 22065207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Curr Top Med Chem; 2012; 12(20):2177-88. PubMed ID: 23231395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection.
    Naoi M; Maruyama W; Akao Y; Yi H; Yamaoka Y
    J Neural Transm Suppl; 2006; (71):67-77. PubMed ID: 17447417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms.
    Naoi M; Maruyama W; Inaba-Hasegawa K
    Expert Rev Neurother; 2013 Jun; 13(6):671-84. PubMed ID: 23739004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage.
    Ou XM; Stockmeier CA; Meltzer HY; Overholser JC; Jurjus GJ; Dieter L; Chen K; Lu D; Johnson C; Youdim MB; Austin MC; Luo J; Sawa A; May W; Shih JC
    Biol Psychiatry; 2010 May; 67(9):855-63. PubMed ID: 20022592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection.
    Naoi M; Maruyama W; Inaba-Hasegawa K; Akao Y
    Int Rev Neurobiol; 2011; 100():85-106. PubMed ID: 21971004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection.
    Wu Y; Kazumura K; Maruyama W; Osawa T; Naoi M
    J Neural Transm (Vienna); 2015 Oct; 122(10):1399-407. PubMed ID: 25863936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A; McGeer PL
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
    Naoi M; Maruyama W
    Curr Pharm Des; 2010; 16(25):2799-817. PubMed ID: 20698822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy?
    Maruyama W; Naoi M
    J Neural Transm (Vienna); 2013 Jan; 120(1):83-9. PubMed ID: 22892822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanism and Structure-activity Relationship of the Inhibition Effect between Monoamine Oxidase and Selegiline Analogues.
    Yang C; Wang X; Gao C; Liu Y; Ma Z; Zang J; Wang H; Liu L; Liu Y; Sun H; Wang W
    Curr Comput Aided Drug Des; 2024; 20(5):474-485. PubMed ID: 37138424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2006; (71):53-65. PubMed ID: 17447416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selegiline reduces cisplatin-induced neuronal death in neuroblastoma cells.
    Müller T; Przuntek H; Rieks M; Mackowiak A
    Neurol Res; 2008 May; 30(4):417-9. PubMed ID: 18237459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal selegiline: targeted effects on monoamine oxidases in the brain.
    Wecker L; James S; Copeland N; Pacheco MA
    Biol Psychiatry; 2003 Nov; 54(10):1099-104. PubMed ID: 14625153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.